Research and Development
Shares drop at Santhera after FDA requires more trial data DMD drug
July 15, 2016 Medical Communications, Research and Development Duchenne Muscular Dystrophy, FDA, santhera
Celgene says its Revlimid gets European approval to treat rare non-Hodgkin’s lymphoma
July 15, 2016 Medical Communications, Research and Development, Sales and Marketing Celgene, European Commission, Revlimid, drug approval, drug trial, oncology
Pfizer announces strong Phase III results for atopic dermatitis drug
July 14, 2016 Research and Development Pfizer, anacor, atopic dermatitis, crisaborole, eczema
Lilly, Boehringer Ingelheim to jointly study combination therapy for breast cancer
July 14, 2016 Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, breast cancer, combination therapy, drug trial
Amgen agrees deal to commercialise biosimilars in Japan with Daiichi Sankyo
July 14, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Daiichi Sankyo, Japan, biosimilars
FDA recommends Novartis’s biosimilar for Enbrel in unanimous vote
July 14, 2016 Research and Development, Sales and Marketing Enbrel, FDA, Novartis, Sandoz, biosimilar
Janssen’s New Drug Application for drug to treat intestinal worms gets US FDA priority review
July 14, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Johnson & Johnson, US FDA, WHO, drug trial, new drug application, regulation, soil-transmitted helminthiasis
US FDA committee recommends approval for Amgen’s biosimilar of AbbVie’s Humira
July 13, 2016 Research and Development, Sales and Marketing AbbVie, Amgen, Humira, US FDA, biosimilar, drug approval, drug trial, inflammatory diseases, rheumatoid arthritis
US FDA lifts hold on Juno’s CAR-T therapy trials; shares jump
July 13, 2016 Research and Development, Sales and Marketing Stock Price, US FDA, drug trial, juno therapeutics
Pfizer gets approval expansion from FDA for pneumonia vaccine
July 13, 2016 Research and Development, Sales and Marketing FDA, Pfizer, Prevnar 13, adults, approval
Scottish regulators back BMS’ Opdivo for lung cancer
July 13, 2016 Research and Development, Sales and Marketing Bristol-Myers Sqibb, NICE, Scottish Medicines Consortium, lung cancer, opdivo, regulation
Nice backs UCB’s Cimzia as alternate therapy for severe rheumatoid arthritis
July 13, 2016 Research and Development, Sales and Marketing Cimzia, NICE, UCB, regulation, rheumatoid arthritis
Shares tumble at CytRx as lead oncology candidate fails to impress in Phase III
July 12, 2016 Manufacturing and Production, Research and Development aldoxorubicin, cytrx
Coherus BioSciences says Neulasta biosimilar shows positive topline results; shares jump
July 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Cancer, Coherus BioSciences, biosimilar, drug trial
Ipsen’s CEO to step down, names new chief executive
July 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
